Goodrx Holdings Inc saw the highest growth of 0.99% in patent filings and no patents were granted in May in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.99% and no change in grants. GlobalData’s DataBook provides a comprehensive analysis of Goodrx Holdings Inc’s patent filings and grants. Buy the databook here.
Goodrx Holdings Inc has been focused on protecting inventions in United States(US) with one publication in Q2 2024
The United States(US) Patent Office dominates the patent filings with nearly 100% of filings. The United States(US) patent Office are among the top ten patent offices where Goodrx Holdings Inc is filings its patents..
International Business Machines and Roche could be the strongest competitors for Goodrx Holdings Inc
Patents related to fintech and insurtech lead Goodrx Holdings Inc's portfolio
Goodrx Holdings Inc has the highest number of patents in fintech followed by, insurtech and healthtech. For fintech, nearly 10% of patents were filed and no patents were granted in Q2 2024.
Insurance related patents lead Goodrx Holdings Inc portfolio followed by medical insurance, and reinsurance
Goodrx Holdings Inc has highest number of patents in insurance followed by medical insurance, reinsurance, other remote patient monitoring, and retail.
For comprehensive analysis of Goodrx Holdings Inc's filings and grants, buy the databook here.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.